SPAC222.17 is a protein in Schizosaccharomyces pombe (fission yeast) identified by the UniProt Number C6Y4B9. While detailed functional characterization appears limited in current literature, related proteins in the same genomic region (such as SPAC222.19) have been investigated in the context of complex formation with other proteins. Research suggests that proteins in this family may be involved in cellular regulatory pathways similar to the Ragulator complex, which plays roles in cellular growth regulation through TOR complex signaling . The antibody against SPAC222.17 provides a valuable tool for investigating this protein's expression, localization, and potential interactions in S. pombe.
The SPAC222.17 antibody has been validated for two primary applications:
These applications make the antibody suitable for both quantitative analysis of SPAC222.17 levels and qualitative detection of the protein in cellular extracts, allowing researchers to investigate expression patterns and post-translational modifications.
The SPAC222.17 antibody package typically includes:
200μg antigens (intended as positive control)
1ml pre-immune serum (intended as negative control)
This comprehensive set of components enables proper experimental design with appropriate controls. The positive control antigen helps verify antibody performance and establishes detection parameters, while the pre-immune serum serves as a critical negative control to identify potential non-specific binding. These controls should be incorporated into each experimental run to ensure reliable and interpretable results.
For optimal Western blot results with SPAC222.17 antibody, we recommend following this protocol adapted from established S. pombe research methodologies:
Sample Preparation:
Harvest cells in 10% trichloroacetic acid (TCA)
Prepare crude cell lysates according to established protocols
Determine protein concentration using Bio-Rad protein assay kit
SDS-PAGE and Transfer:
Resolve proteins by SDS-PAGE
Transfer to nitrocellulose membrane
Immunoblotting:
Block membrane with 5% non-fat milk in TBST
Incubate with SPAC222.17 antibody (recommended dilution: 1:1000)
Wash with TBST buffer (3 × 10 minutes)
Incubate with appropriate secondary antibody
Wash thoroughly with TBST
Detection:
For loading controls in S. pombe studies, anti-Spc1 antibody is commonly used as it provides consistent signals across various experimental conditions .
Based on protocols established for working with similar antibodies in S. pombe:
Cell Preparation:
Grow cells to exponential phase in YES medium
Filter onto 0.45 μm mixed cellulose ester membrane
Cell Lysis:
Disrupt cells in lysis buffer containing:
20 mM HEPES-KOH (pH 7.5)
150 mM potassium glutamate
10% glycerol
0.25% Tween-20
10 mM sodium fluoride
10 mM p-nitrophenylphosphate
10 mM sodium pyrophosphate
10 mM β-glycerophosphate
0.1 mM sodium orthovanadate
Protease inhibitors (PMSF, leupeptin, and protease inhibitor cocktail)
Use glass beads with a Multi-beads Shocker or similar device
Immunoprecipitation:
For validation of novel interactions, serial immunoprecipitation with differently tagged proteins is recommended, followed by mass spectrometry analysis to identify complex components.
ChIP optimization for SPAC222.17 antibody should follow these key steps:
Crosslinking Optimization:
Test different formaldehyde concentrations (0.5-1.5%)
Optimize crosslinking times (5-20 minutes) at room temperature
Sonication Parameters:
Adjust sonication conditions to produce DNA fragments of 200-500 bp
Verify fragmentation efficiency by agarose gel electrophoresis
Antibody Validation:
Perform titration experiments to determine optimal antibody concentration
Include IgG controls and input samples
Immunoprecipitation Conditions:
Test different bead types (Protein A, Protein G, or magnetic beads)
Optimize incubation times and temperatures
Washing Stringency:
Evaluate different wash buffer compositions to minimize background
Consider including a pre-clearing step to reduce non-specific binding
Analysis Methods:
Research indicates that ChIP profiles obtained with different antibodies targeting the same complex often show >95% peak overlap when optimized correctly .
To characterize protein complexes involving SPAC222.17, consider these approaches:
Tandem Affinity Purification:
Generate strains with tagged SPAC222.17 (e.g., FLAG, myc)
Perform successive immunoprecipitation procedures
Analyze co-purified proteins by mass spectrometry
Co-immunoprecipitation Experiments:
Use SPAC222.17 antibody for immunoprecipitation
Identify interaction partners through immunoblotting or mass spectrometry
Validate interactions through reciprocal co-immunoprecipitation
Two-hybrid Analysis:
Screen for interaction partners using SPAC222.17 as bait
Confirm positive interactions by subsequent biochemical assays
Fluorescence Microscopy:
Visualize protein co-localization using fluorescently tagged proteins
Analyze cellular distribution patterns in different growth conditions
Collect Z-axial images and perform deconvolution for accurate spatial analysis
This strategy has successfully identified novel protein complexes in S. pombe, as demonstrated with the Lam protein complex formation, where similar approaches revealed interactions between previously uncharacterized proteins .
| Issue | Possible Causes | Solutions |
|---|---|---|
| Weak or no signal in Western blot | - Insufficient protein loading - Inefficient transfer - Suboptimal antibody dilution - Degraded protein sample | - Increase protein load (30-50 μg recommended) - Optimize transfer conditions - Test different antibody dilutions (1:500-1:2000) - Add additional protease inhibitors during sample preparation |
| High background | - Insufficient blocking - Antibody concentration too high - Inadequate washing | - Extend blocking time (2-4 hours) - Increase BSA/milk concentration in blocking buffer - Dilute primary antibody further - Increase wash duration and frequency |
| Multiple bands | - Cross-reactivity - Post-translational modifications - Protein degradation | - Use pre-absorption with recombinant antigen - Include phosphatase inhibitors if phosphorylation suspected - Prepare fresh samples with additional protease inhibitors |
| Inconsistent results | - Variations in cell culture conditions - Sample preparation inconsistencies - Antibody storage issues | - Standardize growth conditions - Document detailed sample preparation protocols - Aliquot antibody and avoid freeze-thaw cycles |
To maintain optimal performance of the SPAC222.17 antibody:
Storage Conditions:
Working Solution Preparation:
Thaw aliquots on ice
Centrifuge briefly before opening to collect solution at the bottom
Prepare working dilutions fresh on the day of use
Stability Considerations:
Working dilutions may be stored at 4°C for up to one week
Monitor antibody performance periodically with positive controls
Document lot numbers and performance to track potential variability
Contamination Prevention:
Use sterile techniques when handling the antibody
Avoid contamination with microorganisms or chemicals
Include sodium azide (0.02%) for longer-term storage of working dilutions
A comprehensive experimental design with SPAC222.17 antibody should include:
Positive Controls:
Negative Controls:
Loading/Normalization Controls:
Procedural Controls:
Secondary antibody only control to identify non-specific binding
Peptide competition assay to demonstrate specificity
Cross-reactivity assessment with related proteins
Validation Approach:
Use of multiple detection techniques (Western blot, immunofluorescence)
Correlation of results with orthogonal methods (RT-PCR, RNA-seq)
To verify antibody specificity, researchers should implement these approaches:
Genetic Validation:
Compare signal in wild-type vs. SPAC222.17 knockout/knockdown strains
Test for signal reduction in strains with reduced expression
Molecular Validation:
Perform peptide competition assays using the immunizing antigen
Assess cross-reactivity with related proteins by recombinant protein analysis
Technical Validation:
Compare results from multiple lots of the antibody
Use alternative antibodies targeting different epitopes of SPAC222.17
Validate findings using tagged versions of the protein
Functional Validation:
Correlate antibody detection with expected localization patterns
Confirm antibody detects changes in expression under conditions known to affect the protein
Verify detection of protein-protein interactions through co-immunoprecipitation
Integration of immunoprecipitation with mass spectrometry requires:
Sample Preparation Workflow:
Perform immunoprecipitation using SPAC222.17 antibody
Resolve samples by SDS-PAGE
Slice gel into multiple pieces for in-gel trypsin digestion
Mass Spectrometry Analysis:
Data Analysis Considerations:
Filter results based on coverage, number of unique peptides, and score
Compare with control immunoprecipitations to identify specific interactors
Validate key interactions through targeted approaches (Western blot, co-IP)
Quantitative Analysis:
Consider SILAC or TMT labeling for quantitative comparison across conditions
Analyze changes in interaction partners under different cellular states
Correlate complex formation with functional outcomes
This approach has successfully identified novel protein complexes in S. pombe, providing insights into cellular pathways and regulatory mechanisms .
For optimal fluorescence microscopy studies:
Sample Preparation:
Grow cells exponentially in EMM liquid medium
Fix cells with appropriate fixation method (e.g., formaldehyde)
Perform membrane permeabilization and blocking
Immunofluorescence Protocol:
Incubate with SPAC222.17 antibody at optimized dilution
Use appropriate fluorescent secondary antibodies
Include nuclear and vacuolar staining for spatial reference
Imaging Parameters:
Co-localization Studies:
Combine with markers for specific cellular compartments
Use FM4-64 dye for vacuole visualization
Consider tagged versions of SPAC222.17 (GFP, mCherry) for live-cell imaging
Advanced Imaging Techniques:
Consider super-resolution microscopy for detailed localization
Use FRAP or photoactivation to assess protein dynamics
Implement time-lapse imaging to monitor changes during cell cycle progression
These approaches allow comprehensive assessment of protein localization and dynamics in response to various cellular conditions and genetic backgrounds.
The SPAC222.17 antibody could facilitate several innovative research directions:
Pathway Integration Analysis:
Evolutionary Conservation Studies:
Comparative analysis across yeast species (S. pombe, S. cerevisiae)
Identification of functional homologs in higher eukaryotes
Exploration of structural similarities despite limited sequence homology
Stress Response Characterization:
Analysis of SPAC222.17 expression and localization under various stress conditions
Investigation of post-translational modifications in response to cellular signals
Correlation with changes in cellular growth and division
Cell Cycle Regulation:
These approaches could reveal novel insights into fundamental cellular processes and regulatory mechanisms conserved across eukaryotes.
Researchers beginning work with SPAC222.17 antibody should consider:
Experimental Planning:
Technical Approach:
Data Interpretation:
Consider potential cross-reactivity with related proteins
Correlate antibody-based findings with orthogonal techniques
Interpret results in the context of known S. pombe biology
Methodology Development:
Begin with established protocols for S. pombe protein analysis
Systematically optimize each step for SPAC222.17 detection
Create standardized protocols specific to your research questions